XPO1 and neoplasm: In conclusion, the 3D nuclear telomere architecture of tumor cells is preferentially disrupted by XPO1 inhibition, while that of normal cells was minimally or not affected suggesting a tumor cell–specific effect of XPO1 inhibition on nuclear architecture.